Welcome to Molecular Oncology Tumor Boards

The Molecular Oncology Tumor Boards are a series of bi-monthly, user-driven discussions designed to help cancer care providers with the interpretation and understanding of tumor molecular profiling tests and studies. Moderated by an expert pathologist and medical oncologist, each case will be updated with new information over a 2-week period as user comments are added. Sign in with your ASCO username and password to participate. After 2 weeks, the discussion will be locked to further commentary and users will be able to claim CME credit for their participation. Visit ASCO University to learn more. 

To participate in discussions on other oncology-related topics, visit ASCO’s member community on myConnection. Connect with colleagues, build your professional network, exchange ideas, collaborate, and more

LOGIN TO START A DISCUSSION
Molecular Oncology Tumor Board
ASCO University
May 13, 2015 8:54 AM
Read more to answer the following: 1)Was there a role for adjuvant therapy after his original surgery? If yes, what adjuvant chemotherapy would you recommend and why? 2)What treatment would you recommend now? 3)What additional information or testing would you want?
Molecular Oncology Tumor Board
ASCO University
Apr 15, 2015 9:56 AM
Read more to answer the following:
1) Did this patient meet the standard criteria for initiation of therapy for his CLL? 2) What genetic tests were indicated prior to initial treatment of the patient’s CLL? 3) Do you consider fludarabine monotherapy to be a suitable therapy for this patient in 2015?
Molecular Oncology Tumor Board
ASCO University
Mar 11, 2015 10:52 AM
User Instructions: Welcome to the Molecular Oncology Tumor Board Series! This educational initiative is a collaboration between the American Society of Clinical Oncology (ASCO), College of American Pathologists (CAP), and Association for Molecular Pathology (AMP).
A new case will be presented each...
Molecular Oncology Tumor Board
ASCO University
Feb 11, 2015 9:33 AM
User Instructions: Welcome to the Molecular Oncology Tumor Board Series! This educational initiative is a collaboration between the American Society of Clinical Oncology (ASCO), College of American Pathologists (CAP), and Association for Molecular Pathology (AMP).

A new case will be presented each...
Molecular Oncology Tumor Board
ASCO University
Jan 14, 2015 9:31 AM
User Instructions: Welcome to the Molecular Oncology Tumor Board Series! This educational initiative is a collaboration between the American Society of Clinical Oncology (ASCO), College of American Pathologists (CAP), and Association for Molecular Pathology (AMP).

A new case will be presented each...

Pages


Advertisement